ARCHIMED
About ARCHIMED
ARCHIMED is a global investment firm focused on accelerating the development of healthcare industries and solutions to improve health outcomes worldwide. The firm funds, supports, and scales healthcare companies across sectors such as medical devices, diagnostics, and life sciences, with a portfolio that includes MedTech and other healthtech businesses. It operates internationally, highlighting activities across Europe and Asia, and emphasizes sustainable returns for investors alongside societal impact in healthcare.
Recent News
H2 2026 Represents a Pivotal Transition for European Ambient Clinical AI
ARCHIMED to Acquire Esperion Therapeutics in a $1.1 Billion Deal
Pharma and Biotech M&As 2026 Deal Watcher
Esperion to Be Bought by ARCHIMED in $1.1 B Deal, Shares Surge 56%
ArchiMed to Take Esperion Therapeutics Private for $1.1bn